PeerView Clinical Pharmacology CME/CNE/CPE Video - Robert D. McBane, II, MD - Taking a New Look at Cancer-Associated Venous Thromboembolism: How Is Emerging Evidence Influencing Guidelines & Practice?

Robert D. McBane, II, MD - Taking a New Look at Cancer-Associated Venous Thromboembolism: How Is Emerging Evidence Influencing Guidelines & Practice?

08/26/19 • 30 min

PeerView Clinical Pharmacology CME/CNE/CPE Video

Go online to PeerView.com/TGQ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in venous thromboembolism (VTE) reviews the latest clinical science and guidelines pertaining to cancer-associated VTE prophylaxis and treatment. This video-based program also focuses on strategies to help learners prepare for the practical integration of direct oral anticoagulants (DOACs) in cancer-associated VTE and illustrates how this development can lead to clinical improvements in the prevention and management of VTE in the cancer setting. Upon completion of this activity, participants will be able to: Use established clinical tools to assess the risk for VTE in patients preparing to receive anticancer therapy, Summarize current evidence and guidelines on VTE treatment and prophylaxis including the use of direct oral anticoagulation in patients with cancer, Apply updated evidence on the use of DOACs as initial VTE therapy and/or thromboprophylaxis in the cancer setting.

Previous Episode

undefined - Doreen Addrizzo-Harris, MD - Advances in the Management of Nontuberculous Mycobacterial Lung Disease (NTM-LD): Expert Insights From Dallas

Doreen Addrizzo-Harris, MD - Advances in the Management of Nontuberculous Mycobacterial Lung Disease (NTM-LD): Expert Insights From Dallas

Go online to PeerView.com/FBD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in nontuberculous mycobacterial lung disease reviews the latest efficacy and safety data presented at the 2019 American Thoracic Society International Conference and offers insight on individualizing treatment plans for patients with nontuberculous mycobacterial lung disease (NTM-LD). Upon completion of this activity, participants should be better able to: Describe the increasing medical burden of NTM-LD, particularly in the population older than age 65, Discuss the latest efficacy and safety data for novel therapies and updates to diagnostic and management guidelines for NTM-LD, Apply late-breaking data to individualized treatment plans for patients with NTM-LD.

Next Episode

undefined - Anthony J. Mancini, MD, FAAP, FAAD - Improving the Care of Young Patients With Atopic Dermatitis: Recognizing the Differences Between Children, Adolescents, and Adults

Anthony J. Mancini, MD, FAAP, FAAD - Improving the Care of Young Patients With Atopic Dermatitis: Recognizing the Differences Between Children, Adolescents, and Adults

Go online to PeerView.com/YGP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this infographic-based activity, an expert dermatologist discusses the burden and clinical manifestations of atopic dermatitis (AD) in children, adolescents, and adults and offers insight into the best practices to improve the care of young patients with this condition. Upon completion of this activity, participants should be better able to: Recognize the burden of disease and unmet needs experienced by pediatric and adolescent patients with atopic dermatitis (AD) and their caregivers, Identify the differences in clinical manifestations and differential diagnoses between children, adolescents, and adults with AD, Discuss the mechanism of action and the latest clinical data related to the efficacy and safety of currently available and emerging treatments for pediatric and adolescent AD, Employ an individualized, proactive approach to the long-term treatment of children and adolescents with AD.